Placeholder image of a protein
Icon representing a puzzle

439: H2N2 Flu Design Puzzle 1b

Closed since over 14 years ago

Intermediate Overall Design

Summary


Created
July 14, 2011
Expires
Max points
100
Description

This is the first of the many new exciting Flu puzzles David Baker mentioned in his blogpost. Our lab designed against the H1N1 subtype of the virus, but a related subtype with pandemic potential, H2N2, has different sidechains in this region that perturb binding. The goal is to design the interface of these designs so that it can bind to the H2 subtype of Influenza. This puzzle is worth 150 global points! If you are new to Foldit, make sure you have completed the Intro Puzzle 4-5 and Design Puzzles 6-1 through 6-4. We've tweaked some parameters since the last time you've seen this protein, so things should be a little different!

Top groups


  1. Avatar for Contenders 100 pts. 7,418
  2. Avatar for Anthropic Dreams 2. Anthropic Dreams 82 pts. 7,414
  3. Avatar for Russian team 3. Russian team 66 pts. 7,410
  4. Avatar for foldeRNA 4. foldeRNA 53 pts. 7,407
  5. Avatar for Void Crushers 5. Void Crushers 42 pts. 7,407
  6. Avatar for SETI.Germany 6. SETI.Germany 33 pts. 7,401
  7. Avatar for Go Science 7. Go Science 26 pts. 7,400
  8. Avatar for Deleted group 8. Deleted group pts. 7,392
  9. Avatar for L'Alliance Francophone 9. L'Alliance Francophone 15 pts. 7,388
  10. Avatar for Mojo Risin' 10. Mojo Risin' 11 pts. 7,380

  1. Avatar for Plupp 151. Plupp Lv 1 2 pts. 7,291
  2. Avatar for TrelosEpistimonas 152. TrelosEpistimonas Lv 1 2 pts. 7,289
  3. Avatar for lemur1 153. lemur1 Lv 1 2 pts. 7,284
  4. Avatar for tim1079 154. tim1079 Lv 1 1 pt. 7,282
  5. Avatar for StewedLionII 155. StewedLionII Lv 1 1 pt. 7,278
  6. Avatar for HillObserver 156. HillObserver Lv 1 1 pt. 7,272
  7. Avatar for multaq 157. multaq Lv 1 1 pt. 7,272
  8. Avatar for Fowardint 158. Fowardint Lv 1 1 pt. 7,271
  9. Avatar for monkry 159. monkry Lv 1 1 pt. 7,266
  10. Avatar for GessGuitar 160. GessGuitar Lv 1 1 pt. 7,264

Comments